[Seite 95↓]

8. Literaturverzeichnis

Abelev, G. I.; Perova, S. D.; Khramkova, N. I.; Postnikova, Z. A. and Irlin, I. S. (1963): Production of embryonal alpha-globulin by transplantable mouse hepatomas, Transplantation 1, pp.174-80. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=14010646

Agarwala, K. L.; Kokame, K.; Kato, H. and Miyata, T. (2000): Phosphorylation of RTP, an ER stress-responsive cytoplasmic protein, Biochem Biophys Res Commun 272 [3], pp.641-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=10860807

Amrani, A.; Verdaguer, J.; Serra, P.; Tafuro, S.; Tan, R. and Santamaria, P. (2000): Progression of autoimmune diabetes driven by avidity maturation of a T-cell population, Nature 406 [6797], pp.739-42. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=10963600

Asadullah, K.; Docke, W. D.; Haeussler, A.; Sterry, W. and Volk, H. D. (1996): Progression of mycosis fungoides is associated with increasing cutaneous expression of interleukin-10 mRNA, J Invest Dermatol 107 [6], pp.833-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=8941670

Bachmair, A. and Varshavsky, A. (1989): The degradation signal in a short-lived protein, Cell 56 [6], pp.1019-32. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=2538246

Bagot, M.; Echchakir, H.; Mami-Chouaib, F.; Delfau-Larue, M. H.; Charue, D.; Bernheim, A.; Chouaib, S.; Boumsell, L. and Bensussan, A. (1998): Isolation of tumor-specific cytotoxic CD4+ and CD4+CD8dim+ T-cell clones infiltrating a cutaneous T-cell lymphoma, Blood 91 [11], pp.4331-41. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9596682

Bagot, M.; Nikolova, M.; Schirm-Chabanette, F.; Wechsler, J.; Boumsell, L. and Bensussan, A. (2001): Crosstalk between tumor T lymphocytes and reactive T lymphocytes in cutaneous T cell lymphomas, Ann N Y Acad Sci 941, pp.31-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11594580

Berger, C. L.; Longley, J.; Hanlon, D.; Girardi, M. and Edelson, R. (2001): The clonotypic T cell receptor is a source of tumor-associated antigens in cutaneous T cell lymphoma, Ann N Y Acad Sci 941, pp.106-22. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11594564

Berger, C. L.; Wang, N.; Christensen, I.; Longley, J.; Heald, P. and Edelson, R. L. (1996): The immune response to class I-associated tumor-specific cutaneous T-cell lymphoma antigens, J Invest Dermatol 107 [3], pp.392-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=8751976

Bernengo, M. G.; Novelli, M.; Quaglino, P.; Lisa, F.; De Matteis, A.; Savoia, P.; Cappello, N. and Fierro, M. T. (2001): The relevance of the CD4+ CD26- subset in the identification of circulating Sezary cells, Br J Dermatol 144 [1], pp.125-35. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11167693

Birmingham, K. (2002): Judah Folkman, Nat Med 8 [10], p.1052. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12357229

Bjorkman, P. J.; Saper, M. A.; Samraoui, B.; Bennett, W. S.; Strominger, J. L. and Wiley, D. C. (1987): Structure of the human class I histocompatibility antigen, HLA-A2, Nature 329 [6139], pp.506-12. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=3309677

Blake, J.; Johnston, J. V.; Hellstrom, K. E.; Marquardt, H. and Chen, L. (1996): Use of combinatorial peptide libraries to construct functional mimics of tumor epitopes recognized by MHC class I-restricted cytolytic T lymphocytes, J Exp Med 184 [1], pp.121-30. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=8691125

Blattman, J. N.; Antia, R.; Sourdive, D. J.; Wang, X.; Kaech, S. M.; Murali-Krishna, K.; Altman, J. D. and Ahmed, R. (2002): Estimating the precursor frequency of naive antigen-specific CD8 T cells, J Exp Med 195 [5], pp.657-64. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11877489

Blom, B.; Verschuren, M. C.; Heemskerk, M. H.; Bakker, A. Q.; van Gastel-Mol, E. J.; Wolvers-Tettero, I. L.; van Dongen, J. J. and Spits, H. (1999): TCR gene rearrangements and expression of the pre-T cell receptor complex during human T-cell differentiation, Blood 93 [9], pp.3033-43. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=10216100

Bobryshev, Y. V.; Lord, R. S.; Watanabe, T. and Ikezawa, T. (1998): The cell adhesion molecule E-cadherin is widely expressed in human atherosclerotic lesions, Cardiovasc Res 40 [1], pp.191-205. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9876332

Bowman, M. R.; Crimmins, M. A.; Yetz-Aldape, J.; Kriz, R.; Kelleher, K. and Herrmann, S. (1994): The cloning of CD70 and its identification as the ligand for CD27, J Immunol 152 [4], pp.1756-61. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=8120384

Braciale, T. J. and Braciale, V. L. (1991): Antigen presentation: structural themes and functional variations, Immunol Today 12 [4], pp.124-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=1711855

Brinckerhoff, L. H.; Kalashnikov, V. V.; Thompson, L. W.; Yamshchikov, G. V.; Pierce, R. A.; Galavotti, H. S.; Engelhard, V. H. and Slingluff, C. L., Jr. (1999): Terminal modifications inhibit proteolytic degradation of an immunogenic MART-1(27-35) peptide: implications for peptide vaccines, Int J Cancer 83 [3], pp.326-34. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=10495424

Brock, R.; Wiesmuller, K. H.; Jung, G. and Walden, P. (1996): Molecular basis for the recognition of two structurally different major histocompatibility complex/peptide complexes by a single T-cell receptor, Proc Natl Acad Sci U S A 93 [23], pp.13108-13. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=8917552

Brown, J. H.; Jardetzky, T. S.; Gorga, J. C.; Stern, L. J.; Urban, R. G.; Strominger, J. L. and Wiley, D. C. (1993): Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1, Nature 364 [6432], pp.33-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=8316295

Bullock, T. N.; Patterson, A. E.; Franlin, L. L.; Notidis, E. and Eisenlohr, L. C. (1997): Initiation codon scanthrough versus termination codon readthrough demonstrates strong potential for major histocompatibility complex class I-restricted cryptic epitope expression, J Exp Med 186 [7], pp.1051-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9314554

Busch, D. H. and Pamer, E. G. (1999): T cell affinity maturation by selective expansion during infection, J Exp Med 189 [4], pp.701-10. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9989985

Butterfield, L. H.; Koh, A.; Meng, W.; Vollmer, C. M.; Ribas, A.; Dissette, V.; Lee, E.; Glaspy, J. A.; McBride, W. H. and Economou, J. S. (1999): Generation of human T-cell responses to an HLA-A2.1-restricted peptide epitope derived from alpha-fetoprotein, Cancer Res 59 [13], pp.3134-42. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=10397256

Cangul, H.; Salnikow, K.; Yee, H.; Zagzag, D.; Commes, T. and Costa, M. (2002): Enhanced expression of a novel protein in human cancer cells: a potential aid to cancer diagnosis, Cell Biol Toxicol 18 [2], pp.87-96. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12046693

Cardinaud, S.; Moris, A.; Fevrier, M.; Rohrlich, P. S.; Weiss, L.; Langlade-Demoyen, P.; Lemonnier, F. A.; Schwartz, O. and Habel, A. (2004): Identification of Cryptic MHC I-restricted Epitopes Encoded by HIV-1 Alternative Reading Frames, J Exp Med 199 [8], pp.1053-1063. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15078897

Carreno, B. M. and Collins, M. (2002): The B7 family of ligands and its receptors: new pathways for costimulation and inhibition of immune responses, Annu Rev Immunol 20, pp.29-53. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11861596

Castelli, C.; Storkus, W. J.; Maeurer, M. J.; Martin, D. M.; Huang, E. C.; Pramanik, B. N.; Nagabhushan, T. L.; Parmiani, G. and Lotze, M. T. (1995): Mass spectrometric identification of a naturally processed melanoma peptide recognized by CD8+ cytotoxic T lymphocytes, J Exp Med 181 [1], pp.363-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=7807017

Chen, J. L.; Dunbar, P. R.; Gileadi, U.; Jager, E.; Gnjatic, S.; Nagata, Y.; Stockert, E.; Panicali, D. L.; Chen, Y. T.; Knuth, A.; Old, L. J. and Cerundolo, V. (2000): Identification of NY-ESO-1 peptide analogues capable of improved stimulation of tumor-reactive CTL, J Immunol 165 [2], pp.948-55. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=10878370

Clay, T. M.; Custer, M. C.; McKee, M. D.; Parkhurst, M.; Robbins, P. F.; Kerstann, K.; Wunderlich, J.; Rosenberg, S. A. and Nishimura, M. I. (1999): Changes in the fine specificity of gp100(209-217)-reactive T cells in patients following vaccination with a peptide modified at an HLA-A2.1 anchor residue, J Immunol 162 [3], pp.1749-55. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9973438

Coulie, P. G.; Lehmann, F.; Lethe, B.; Herman, J.; Lurquin, C.; Andrawiss, M. and Boon, T. (1995): A mutated intron sequence codes for an antigenic peptide recognized by cytolytic T lymphocytes on a human melanoma, Proc Natl Acad Sci U S A 92 [17], pp.7976-80. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=7644523

Crawford, F.; Kozono, H.; White, J.; Marrack, P. and Kappler, J. (1998): Detection of antigen-specific T cells with multivalent soluble class II MHC covalent peptide complexes, Immunity 8 [6], pp.675-82. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9655481

Dal Porto, J.; Johansen, T. E.; Catipovic, B.; Parfiit, D. J.; Tuveson, D.; Gether, U.; Kozlowski, S.; Fearon, D. T. and Schneck, J. P. (1993): A soluble divalent class I major histocompatibility complex molecule inhibits alloreactive T cells at nanomolar concentrations, Proc Natl Acad Sci U S A 90 [14], pp.6671-5. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=8341685

Denzin, L. K. and Cresswell, P. (1995): HLA-DM induces CLIP dissociation from MHC class II alpha beta dimers and facilitates peptide loading, Cell 82 [1], pp.155-65. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=7606781

Derby, M. A.; Wang, J.; Margulies, D. H. and Berzofsky, J. A. (2001): Two intermediate-avidity cytotoxic T lymphocyte clones with a disparity between functional avidity and MHC tetramer staining, Int Immunol 13 [6], pp.817-24. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11369710

Dereure, O.; Portales, P.; Clot, J. and Guilhou, J. J. (2000): Decreased expression of Fas (APO-1/CD95) on peripheral blood CD4+ T lymphocytes in cutaneous T-cell lymphomas, Br J Dermatol 143 [6], pp.1205-10. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11122022

Ding, Y. H.; Smith, K. J.; Garboczi, D. N.; Utz, U.; Biddison, W. E. and Wiley, D. C. (1998): Two human T cell receptors bind in a similar diagonal mode to the HLA-A2/Tax peptide complex using different TCR amino acids, Immunity 8 [4], pp.403-11. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9586631

Dutoit, V.; Rubio-Godoy, V.; Dietrich, P. Y.; Quiqueres, A. L.; Schnuriger, V.; Rimoldi, D.; Lienard, D.; Speiser, D.; Guillaume, P.; Batard, P.; Cerottini, J. C.; Romero, P. and Valmori, D. (2001): Heterogeneous T-cell response to MAGE-A10(254-262): high avidity-specific cytolytic T lymphocytes show superior antitumor activity, Cancer Res 61 [15], pp.5850-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11479225

Dutoit, V.; Rubio-Godoy, V.; Doucey, M. A.; Batard, P.; Lienard, D.; Rimoldi, D.; Speiser, D.; Guillaume, P.; Cerottini, J. C.; Romero, P. and Valmori, D. (2002): Functional avidity of tumor antigen-specific CTL recognition directly correlates with the stability of MHC/peptide multimer binding to TCR, J Immunol 168 [3], pp.1167-71. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11801651

Dutton, R. W. (1996): The regulation of the development of CD8 effector T cells, J Immunol 157 [10], pp.4287-92. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=8906801

Echchakir, H.; Mami-Chouaib, F.; Vergnon, I.; Baurain, J. F.; Karanikas, V.; Chouaib, S. and Coulie, P. G. (2001): A point mutation in the alpha-actinin-4 gene generates an antigenic peptide recognized by autologous cytolytic T lymphocytes on a human lung carcinoma, Cancer Res 61 [10], pp.4078-83. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11358829

Edelman, J. and Meyerson, H. J. (2000): Diminished CD3 expression is useful for detecting and enumerating Sezary cells, Am J Clin Pathol 114 [3], pp.467-77. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=10989648

Eichmuller, S. (2002): Towards defining specific antigens for cutaneous lymphomas, Onkologie 25 [5], pp.448-54. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12415200

Eichmuller, S.; Usener, D.; Thiel, D. and Schadendorf, D. (2003): Tumor-specific antigens in cutaneous T-cell lymphoma: expression and sero-reactivity, Int J Cancer 104 [4], pp.482-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12584747

Eisen, H. N.; Sykulev, Y. and Tsomides, T. J. (1996): Antigen-specific T-cell receptors and their reactions with complexes formed by peptides with major histocompatibility complex proteins, Adv Protein Chem 49, pp.1-56. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=8908296

Esser, P.; Grisanti, S. and Bartz-Schmidt, K. (2001): TGF-beta in uveal melanoma, Microsc Res Tech 52 [4], pp.396-400. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11170298

Evavold, B. D.; Sloan-Lancaster, J.; Wilson, K. J.; Rothbard, J. B. and Allen, P. M. (1995): Specific T cell recognition of minimally homologous peptides: evidence for multiple endogenous ligands, Immunity 2 [6], pp.655-63. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=7540944

Fahmy, T. M.; Bieler, J. G.; Edidin, M. and Schneck, J. P. (2001): Increased TCR avidity after T cell activation: a mechanism for sensing low-density antigen, Immunity 14 [2], pp.135-43. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11239446

Falk, K.; Rotzschke, O.; Stevanovic, S.; Jung, G. and Rammensee, H. G. (1994): Pool sequencing of natural HLA-DR, DQ, and DP ligands reveals detailed peptide motifs, constraints of processing, and general rules, Immunogenetics 39 [4], pp.230-42. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=8119729

Fischer, J. R.; Schindel, M.; Stein, N.; Lahm, H.; Gallati, H.; Krammer, P. H. and Drings, P. (1995): Selective suppression of cytokine secretion in patients with small-cell lung cancer, Ann Oncol 6 [9], pp.921-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=8624296

Fischer, T. C.; Gellrich, S.; Muche, J. M.; Tumenjargal, S.; Audring, H.; Neitzel, H.; Walden, P.; Sterry, W. and Tönnies, H (2004): Genomic aberrations and survival in cutaneous T cell lymphomas, J Inv Dermatol 122 [3], pp.579-586.

Fisk, B.; Savary, C.; Hudson, J. M.; O'Brian, C. A.; Murray, J. L.; Wharton, J. T. and Ioannides, C. G. (1995): Changes in an HER-2 peptide upregulating HLA-A2 expression affect both conformational epitopes and CTL recognition: implications for optimization of antigen presentation and tumor-specific CTL induction, J Immunother Emphasis Tumor Immunol 18 [4], pp.197-209. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=8680648

Flad, T.; Spengler, B.; Kalbacher, H.; Brossart, P.; Baier, D.; Kaufmann, R.; Bold, P.; Metzger, S.; Bluggel, M.; Meyer, H. E.; Kurz, B. and Muller, C. A. (1998): Direct identification of major histocompatibility complex class I-bound tumor-associated peptide antigens of a renal carcinoma cell line by a novel mass spectrometric method, Cancer Res 58 [24], pp.5803-11. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9865739

Fleckenstein, B.; Kalbacher, H.; Muller, C. P.; Stoll, D.; Halder, T.; Jung, G. and Wiesmuller, K. H. (1996): New ligands binding to the human leukocyte antigen class II molecule DRB1*0101 based on the activity pattern of an undecapeptide library, Eur J Biochem 240 [1], pp.71-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=8797837

Fleischer, B. (1994): CD26: a surface protease involved in T-cell activation, Immunol Today 15 [4], pp.180-4. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=7911022

Folkman, J. (2003): Angiogenesis and apoptosis, Semin Cancer Biol 13 [2], pp.159-67. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12654259

Freeman, G. J.; Long, A. J.; Iwai, Y.; Bourque, K.; Chernova, T.; Nishimura, H.; Fitz, L. J.; Malenkovich, N.; Okazaki, T.; Byrne, M. C.; Horton, H. F.; Fouser, L.; Carter, L.; Ling, V.; Bowman, M. R.; Carreno, B. M.; Collins, M.; Wood, C. R. and Honjo, T. (2000): Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation, J Exp Med 192 [7], pp.1027-34. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11015443

Fremont, D. H.; Matsumura, M.; Stura, E. A.; Peterson, P. A. and Wilson, I. A. (1992): Crystal structures of two viral peptides in complex with murine MHC class I H-2Kb, Science 257 [5072], pp.919-27. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=1323877

Galy, A.; Verma, S.; Barcena, A. and Spits, H. (1993): Precursors of CD3+CD4+CD8+ cells in the human thymus are defined by expression of CD34. Delineation of early events in human thymic development, J Exp Med 178 [2], pp.391-401. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=7688021

Garboczi, D. N.; Ghosh, P.; Utz, U.; Fan, Q. R.; Biddison, W. E. and Wiley, D. C. (1996): Structure of the complex between human T-cell receptor, viral peptide and HLA-A2, Nature 384 [6605], pp.134-41. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=8906788

Garcia, K. C.; Degano, M.; Pease, L. R.; Huang, M.; Peterson, P. A.; Teyton, L. and Wilson, I. A. (1998): Structural basis of plasticity in T cell receptor recognition of a self peptide-MHC antigen, Science 279 [5354], pp.1166-72. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9469799

Genestier, L.; Kasibhatla, S.; Brunner, T. and Green, D. R. (1999): Transforming growth factor beta1 inhibits Fas ligand expression and subsequent activation-induced cell death in T cells via downregulation of c-Myc, J Exp Med 189 [2], pp.231-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9892606

Girardi, M.; Lewis, J.; Glusac, E.; Filler, R. B.; Geng, L.; Hayday, A. C. and Tigelaar, R. E. (2002): Resident skin-specific gammadelta T cells provide local, nonredundant regulation of cutaneous inflammation, J Exp Med 195 [7], pp.855-67. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11927630

Guilloux, Y.; Lucas, S.; Brichard, V. G.; Van Pel, A.; Viret, C.; De Plaen, E.; Brasseur, F.; Lethe, B.; Jotereau, F. and Boon, T. (1996): A peptide recognized by human cytolytic T lymphocytes on HLA-A2 melanomas is encoded by an intron sequence of the N-acetylglucosaminyltransferase V gene, J Exp Med 183 [3], pp.1173-83. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=8642259

Gundlach, B. R.; Wiesmuller, K. H.; Junt, T.; Kienle, S.; Jung, G. and Walden, P. (1996): Specificity and degeneracy of minor histocompatibility antigen-specific MHC-restricted CTL, J Immunol 156 [10], pp.3645-51. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=8621898

Guy-Grand, D.; Cerf-Bensussan, N.; Malissen, B.; Malassis-Seris, M.; Briottet, C. and Vassalli, P. (1991): Two gut intraepithelial CD8+ lymphocyte populations with different T cell receptors: a role for the gut epithelium in T cell differentiation, J Exp Med 173 [2], pp.471-81. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=1824857

Hasegawa, H.; Nomura, T.; Kohno, M.; Tateishi, N.; Suzuki, Y.; Maeda, N.; Fujisawa, R.; Yoshie, O. and Fujita, S. (2000): Increased chemokine receptor CCR7/EBI1 expression enhances the infiltration of lymphoid organs by adult T-cell leukemia cells, Blood 95 [1], pp.30-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=10607681

Hayday, A. C. (2000): [gamma][delta] cells: a right time and a right place for a conserved third way of protection, Annu Rev Immunol 18, pp.975-1026. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=10837080

Hemmer, B.; Fleckenstein, B. T.; Vergelli, M.; Jung, G.; McFarland, H.; Martin, R. and Wiesmuller, K. H. (1997): Identification of high potency microbial and self ligands for a human autoreactive class II-restricted T cell clone, J Exp Med 185 [9], pp.1651-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9151902

Hemmer, B.; Pinilla, C.; Gran, B.; Vergelli, M.; Ling, N.; Conlon, P.; McFarland, H. F.; Houghten, R. and Martin, R. (2000): Contribution of individual amino acids within MHC molecule or antigenic peptide to TCR ligand potency, J Immunol 164 [2], pp.861-71. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=10623833

Herr, I.; Wilhelm, D.; Bohler, T.; Angel, P. and Debatin, K. M. (1997): Activation of CD95 (APO-1/Fas) signaling by ceramide mediates cancer therapy-induced apoptosis, Embo J 16 [20], pp.6200-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9321399

Hin, S.; Zabel, C.; Bianco, A.; Jung, G. and Walden, P. (1999): Cutting edge: N-hydroxy peptides: a new class of TCR antagonists, J Immunol 163 [5], pp.2363-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=10452967

Hindkjaer, J.; Brandt, C. A. and Kaltoft, K. (1993): Aneuploid malignant T cells from a patient with Sezary syndrome can be visualized by in situ hybridization, Arch Dermatol 129 [9], pp.1141-5. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=8363397

Hintzen, R. Q.; de Jong, R.; Lens, S. M. and van Lier, R. A. (1994): CD27: marker and mediator of T-cell activation?, Immunol Today 15 [7], pp.307-11. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=8086099

Horwitz, D. A.; Zheng, S. G. and Gray, J. D. (2003): The role of the combination of IL-2 and TGF-beta or IL-10 in the generation and function of CD4+ CD25+ and CD8+ regulatory T cell subsets, J Leukoc Biol 74 [4], pp.471-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=14519757

Howie, D.; Spencer, J.; DeLord, D.; Pitzalis, C.; Wathen, N. C.; Dogan, A.; Akbar, A. and MacDonald, T. T. (1998): Extrathymic T cell differentiation in the human intestine early in life, J Immunol 161 [11], pp.5862-72. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9834065

Hu, H. M.; Dols, A.; Meijer, S. L.; Floyd, K.; Walker, E.; Urba, W. J. and Fox, B. A. (2004): Immunological monitoring of patients with melanoma after peptide vaccination using soluble peptide/HLA-A2 dimer complexes, J Immunother 27 [1], pp.48-59. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=14676633

Hunt, D. F.; Michel, H.; Dickinson, T. A.; Shabanowitz, J.; Cox, A. L.; Sakaguchi, K.; Appella, E.; Grey, H. M. and Sette, A. (1992): Peptides presented to the immune system by the murine class II major histocompatibility complex molecule I-Ad, Science 256 [5065], pp.1817-20. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=1319610

Jensenius, J. C. and Williams, A. F. (1982): The T lymphocyte antigen receptor--paradigm lost, Nature 300 [5893], pp.583-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=6755269

Jochmus, I.; Osen, W.; Altmann, A.; Buck, G.; Hofmann, B.; Schneider, A.; Gissmann, L. and Rammensee, H. G. (1997): Specificity of human cytotoxic T lymphocytes induced by a human papillomavirus type 16 E7-derived peptide, J Gen Virol 78 ( Pt 7), pp.1689-95. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9225046

Jones, D.; Dang, N. H.; Duvic, M.; Washington, L. T. and Huh, Y. O. (2001): Absence of CD26 expression is a useful marker for diagnosis of T-cell lymphoma in peripheral blood, Am J Clin Pathol 115 [6], pp.885-92. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11392886

Ju, S. T.; Panka, D. J.; Cui, H.; Ettinger, R.; el-Khatib, M.; Sherr, D. H.; Stanger, B. Z. and Marshak-Rothstein, A. (1995): Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation, Nature 373 [6513], pp.444-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=7530337

Kalergis, A. M.; Boucheron, N.; Doucey, M. A.; Palmieri, E.; Goyarts, E. C.; Vegh, Z.; Luescher, I. F. and Nathenson, S. G. (2001): Efficient T cell activation requires an optimal dwell-time of interaction between the TCR and the pMHC complex, Nat Immunol 2 [3], pp.229-34. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11224522

Kaltoft, K.; Bisballe, S.; Dyrberg, T.; Boel, E.; Rasmussen, P. B. and Thestrup-Pedersen, K. (1992): Establishment of two continuous T-cell strains from a single plaque of a patient with mycosis fungoides, In Vitro Cell Dev Biol 28A [3 Pt 1], pp.161-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=1582990

Kaltoft, K.; Bisballe, S.; Rasmussen, H. F.; Thestrup-Pedersen, K.; Thomsen, K. and Sterry, W. (1987): A continuous T-cell line from a patient with Sezary syndrome, Arch Dermatol Res 279 [5], pp.293-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=3498444

Karenko, L.; Hyytinen, E.; Sarna, S. and Ranki, A. (1997): Chromosomal abnormalities in cutaneous T-cell lymphoma and in its premalignant conditions as detected by G-banding and interphase cytogenetic methods, J Invest Dermatol 108 [1], pp.22-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=8980281

Kelly, A. P.; Monaco, J. J.; Cho, S. G. and Trowsdale, J. (1991): A new human HLA class II-related locus, DM, Nature 353 [6344], pp.571-3. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=1922365

Kersh, G. J.; Miley, M. J.; Nelson, C. A.; Grakoui, A.; Horvath, S.; Donermeyer, D. L.; Kappler, J.; Allen, P. M. and Fremont, D. H. (2001): Structural and functional consequences of altering a peptide MHC anchor residue, J Immunol 166 [5], pp.3345-54. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11207290

Kokame, K.; Kato, H. and Miyata, T. (1998): Nonradioactive differential display cloning of genes induced by homocysteine in vascular endothelial cells, Methods 16 [4], pp.434-43. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=10049651

Kuon, W.; Holzhutter, H. G.; Appel, H.; Grolms, M.; Kollnberger, S.; Traeder, A.; Henklein, P.; Weiss, E.; Thiel, A.; Lauster, R.; Bowness, P.; Radbruch, A.; Kloetzel, P. M. and Sieper, J. (2001): Identification of HLA-B27-restricted peptides from the Chlamydia trachomatis proteome with possible relevance to HLA-B27-associated diseases, J Immunol 167 [8], pp.4738-46. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11591805

Kurdistani, S. K.; Arizti, P.; Reimer, C. L.; Sugrue, M. M.; Aaronson, S. A. and Lee, S. W. (1998): Inhibition of tumor cell growth by RTP/rit42 and its responsiveness to p53 and DNA damage, Cancer Res 58 [19], pp.4439-44. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9766676

La Rosa, C.; Krishnan, R.; Markel, S.; Schneck, J. P.; Houghten, R.; Pinilla, C. and Diamond, D. J. (2001): Enhanced immune activity of cytotoxic T-lymphocyte epitope analogs derived from positional scanning synthetic combinatorial libraries, Blood 97 [6], pp.1776-86. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11238120

Lachat, P.; Shaw, P.; Gebhard, S.; van Belzen, N.; Chaubert, P. and Bosman, F. T. (2002): Expression of NDRG1, a differentiation-related gene, in human tissues, Histochem Cell Biol 118 [5], pp.399-408. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12432451

Laetsch, B.; Haffner, A. C.; Dobbeling, U.; Seifert, B.; Ludwig, E.; Burg, G. and Dummer, R. (2000): CD4 + /CD7- T cell frequency and polymerase chain reaction-based clonality assay correlate with stage in cutaneous T cell lymphomas, J Invest Dermatol 114 [1], pp.107-11. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=10620124

Lanzavecchia, A. (1998): Immunology. Licence to kill, Nature 393 [6684], pp.413-4. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9623994

Le Bouteiller, P. and Lenfant, F. (1996): Antigen-presenting function(s) of the non-classical HLA-E, -F and -G class I molecules: the beginning of a story, Res Immunol 147 [5], pp.301-13. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=8876058

Lee, P. P.; Yee, C.; Savage, P. A.; Fong, L.; Brockstedt, D.; Weber, J. S.; Johnson, D.; Swetter, S.; Thompson, J.; Greenberg, P. D.; Roederer, M. and Davis, M. M. (1999): Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients, Nat Med 5 [6], pp.677-85. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=10371507

Lin, T. M. and Chang, C. (1997): Cloning and characterization of TDD5, an androgen target gene that is differentially repressed by testosterone and dihydrotestosterone, Proc Natl Acad Sci U S A 94 [10], pp.4988-93. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9144177

Linnemann, T.; Brock, C.; Sparbier, K.; Muche, M.; Mielke, A.; Lukowsky, A.; Sterry, W.; Kaltoft, K.; Wiesmuller, K. H. and Walden, P. (1998): Identification of epitopes for CTCL-specific cytotoxic T lymphocytes, Adv Exp Med Biol 451, pp.231-5. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=10026877

Linnemann, T.; Tumenjargal, S.; Gellrich, S.; Wiesmuller, K.; Kaltoft, K.; Sterry, W. and Walden, P. (2001): Mimotopes for tumor-specific T lymphocytes in human cancer determined with combinatorial peptide libraries, Eur J Immunol 31 [1], pp.156-65. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11169449

Liu, C.; Zhang, L.; Shao, Z. M.; Beatty, P.; Sartippour, M.; Lane, T. F.; Barsky, S. H.; Livingston, E. and Nguyen, M. (2002): Identification of a novel endothelial-derived gene EG-1, Biochem Biophys Res Commun 290 [1], pp.602-12. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11779215

Liu, H.; Hu, B.; Xu, D. and Liew, F. Y. (2003): CD4+CD25+ regulatory T cells cure murine colitis: the role of IL-10, TGF-beta, and CTLA4, J Immunol 171 [10], pp.5012-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=14607897

Liyanage, U. K.; Moore, T. T.; Joo, H. G.; Tanaka, Y.; Herrmann, V.; Doherty, G.; Drebin, J. A.; Strasberg, S. M.; Eberlein, T. J.; Goedegebuure, P. S. and Linehan, D. C. (2002): Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma, J Immunol 169 [5], pp.2756-61. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12193750

Long, E. O.; LaVaute, T.; Pinet, V. and Jaraquemada, D. (1994): Invariant chain prevents the HLA-DR-restricted presentation of a cytosolic peptide, J Immunol 153 [4], pp.1487-94. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=8046228

Longthorne, V. L. and Williams, G. T. (1997): Caspase activity is required for commitment to Fas-mediated apoptosis, Embo J 16 [13], pp.3805-12. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9233790

Lucas, M.; Day, C. L.; Wyer, J. R.; Cunliffe, S. L.; Loughry, A.; McMichael, A. J. and Klenerman, P. (2004): Ex vivo phenotype and frequency of influenza virus-specific CD4 memory T cells, J Virol 78 [13], pp.7284-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15194806

MacLennan, I. C.; Gotch, F. M. and Golstein, P. (1980): Limited specific T-cell mediated cytolysis in the absence of extracellular Ca2+, Immunology 39 [1], pp.109-17. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=6769782

Malarkannan, S.; Afkarian, M. and Shastri, N. (1995): A rare cryptic translation product is presented by Kb major histocompatibility complex class I molecule to alloreactive T cells, J Exp Med 182 [6], pp.1739-50. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=7500018

Maldonado, A.; Mueller, Y. M.; Thomas, P.; Bojczuk, P.; O'Connors, C. and Katsikis, P. D. (2003): Decreased effector memory CD45RA+ CD62L- CD8+ T cells and increased central memory CD45RA- CD62L+ CD8+ T cells in peripheral blood of rheumatoid arthritis patients, Arthritis Res Ther 5 [2], pp.R91-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12718752

Mason, D. (1998): A very high level of crossreactivity is an essential feature of the T-cell receptor, Immunol Today 19 [9], pp.395-404. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9745202

Masson, D. and Tschopp, J. (1987): A family of serine esterases in lytic granules of cytolytic T lymphocytes, Cell 49 [5], pp.679-85. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=3555842

McHugh, R. S.; Whitters, M. J.; Piccirillo, C. A.; Young, D. A.; Shevach, E. M.; Collins, M. and Byrne, M. C. (2002): CD4(+)CD25(+) immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor, Immunity 16 [2], pp.311-23. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11869690

Mielke, V.; Staib, G.; Boehncke, W. H.; Duller, B. and Sterry, W. (1994): Clonal disease in early cutaneous T-cell lymphoma, Dermatol Clin 12 [2], pp.351-60. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=8045047

Muche, J. M.; Lukowsky, A.; Asadullah, K.; Gellrich, S. and Sterry, W. (1997): Demonstration of frequent occurrence of clonal T cells in the peripheral blood of patients with primary cutaneous T-cell lymphoma, Blood 90 [4], pp.1636-42. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9269783

Nabholz, M. and Tschopp, J. (1989): CTL-mediated cytolysis: perforin and alternative pathways?, Immunol Lett 20 [3], pp.179-80. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=2785499

Nakagawa, T.; Roth, W.; Wong, P.; Nelson, A.; Farr, A.; Deussing, J.; Villadangos, J. A.; Ploegh, H.; Peters, C. and Rudensky, A. Y. (1998): Cathepsin L: critical role in Ii degradation and CD4 T cell selection in the thymus, Science 280 [5362], pp.450-3. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9545226

Nakamura, K.; Kitani, A. and Strober, W. (2001): Cell contact-dependent immunosuppression by CD4(+)CD25(+) regulatory T cells is mediated by cell surface-bound transforming growth factor beta, J Exp Med 194 [5], pp.629-44. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11535631

Nasu, K.; Said, J.; Vonderheid, E.; Olerud, J.; Sako, D. and Kadin, M. (1985): Immunopathology of cutaneous T-cell lymphomas, Am J Pathol 119 [3], pp.436-47. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=3893149

Nguyen, M.; Corless, C. L.; Kraling, B. M.; Tran, C.; Atha, T.; Bischoff, J. and Barsky, S. H. (1997): Vascular expression of E-selectin is increased in estrogen-receptor-negative breast cancer: a role for tumor-cell-secreted interleukin-1 alpha, Am J Pathol 150 [4], pp.1307-14. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9094987

Ni, X.; Hazarika, P.; Zhang, C.; Talpur, R. and Duvic, M. (2001): Fas ligand expression by neoplastic T lymphocytes mediates elimination of CD8+ cytotoxic T lymphocytes in mycosis fungoides: a potential mechanism of tumor immune escape?, Clin Cancer Res 7 [9], pp.2682-92. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11555580

Nielsen, M. B.; Kirkin, A. F.; Loftus, D.; Nissen, M. H.; Rivoltini, L.; Zeuthen, J.; Geisler, C. and Odum, N. (2000): Amino acid substitutions in the melanoma antigen recognized by T cell 1 peptide modulate cytokine responses in melanoma-specific T cells, J Immunother 23 [4], pp.405-11. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=10916749

Nikolova, M.; Bagot, M.; Boumsell, L. and Bensussan, A. (2002): Identification of cell surface molecules characterizing human cutaneous T-cell lymphomas, Leuk Lymphoma 43 [4], pp.741-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12153159

Nocentini, G.; Giunchi, L.; Ronchetti, S.; Krausz, L. T.; Bartoli, A.; Moraca, R.; Migliorati, G. and Riccardi, C. (1997): A new member of the tumor necrosis factor/nerve growth factor receptor family inhibits T cell receptor-induced apoptosis, Proc Natl Acad Sci U S A 94 [12], pp.6216-21. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9177197

Novellino, L.; Renkvist, N.; Rini, F.; Mazzocchi, A.; Rivoltini, L.; Greco, A.; Deho, P.; Squarcina, P.; Robbins, P. F.; Parmiani, G. and Castelli, C. (2003): Identification of a mutated receptor-like protein tyrosine phosphatase kappa as a novel, class II HLA-restricted melanoma antigen, J Immunol 170 [12], pp.6363-70. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12794170

Oxenius, A.; Bachmann, M. F.; Ashton-Rickardt, P. G.; Tonegawa, S.; Zinkernagel, R. M. and Hengartner, H. (1995): Presentation of endogenous viral proteins in association with major histocompatibility complex class II: on the role of intracellular compartmentalization, invariant chain and the TAP transporter system, Eur J Immunol 25 [12], pp.3402-11. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=8566030

Parham, P. (2000): NK cell receptors: of missing sugar and missing self, Curr Biol 10 [5], pp.R195-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=10712900

Pasternack, M. S.; Verret, C. R.; Liu, M. A. and Eisen, H. N. (1986): Serine esterase in cytolytic T lymphocytes, Nature 322 [6081], pp.740-3. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=3489187

Pfreundschuh, M.; Shiku, H.; Takahashi, T.; Ueda, R.; Ransohoff, J.; Oettgen, H. F. and Old, L. J. (1978): Serological analysis of cell surface antigens of malignant human brain tumors, Proc Natl Acad Sci U S A 75 [10], pp.5122-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=283420

Pinet, V. M. and Long, E. O. (1998): Peptide loading onto recycling HLA-DR molecules occurs in early endosomes, Eur J Immunol 28 [3], pp.799-804. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9541573

Pinet, V.; Malnati, M. S. and Long, E. O. (1994): Two processing pathways for the MHC class II-restricted presentation of exogenous influenza virus antigen, J Immunol 152 [10], pp.4852-60. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=8176208

Pinilla, C.; Rubio-Godoy, V.; Dutoit, V.; Guillaume, P.; Simon, R.; Zhao, Y.; Houghten, R. A.; Cerottini, J. C.; Romero, P. and Valmori, D. (2001): Combinatorial peptide libraries as an alternative approach to the identification of ligands for tumor-reactive cytolytic T lymphocytes, Cancer Res 61 [13], pp.5153-60. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11431354

Podack ER, Konigsberg PJ. (1984): Cytolytic T cell granules. Isolation, structural, biochemical, and functional characterization., J Exp Med. 1984 Sep 1;160(3):695-710..

Polverini, P. J. (1996): Cellular adhesion molecules. Newly identified mediators of angiogenesis, Am J Pathol 148 [4], pp.1023-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=8644843

Powell, D. J., Jr. and Rosenberg, S. A. (2004): Phenotypic and functional maturation of tumor antigen-reactive CD8+ T lymphocytes in patients undergoing multiple course peptide vaccination, J Immunother 27 [1], pp.36-47. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=14676632

Rammensee, H. G.; Friede, T. and Stevanoviic, S. (1995): MHC ligands and peptide motifs: first listing, Immunogenetics 41 [4], pp.178-228. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=7890324

Rappl, G.; Muche, J. M.; Abken, H.; Sterry, W.; Tilgen, W.; Ugurel, S. and Reinhold, U. (2001): CD4(+)CD7(-) T cells compose the dominant T-cell clone in the peripheral blood of patients with Sezary syndrome, J Am Acad Dermatol 44 [3], pp.456-61. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11209115

Rees, W.; Bender, J.; Teague, T. K.; Kedl, R. M.; Crawford, F.; Marrack, P. and Kappler, J. (1999): An inverse relationship between T cell receptor affinity and antigen dose during CD4(+) T cell responses in vivo and in vitro, Proc Natl Acad Sci U S A 96 [17], pp.9781-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=10449771

Rezvani, K.; Grube, M.; Brenchley, J. M.; Sconocchia, G.; Fujiwara, H.; Price, D. A.; Gostick, E.; Yamada, K.; Melenhorst, J.; Childs, R.; Hensel, N.; Douek, D. C. and Barrett, A. J. (2003): Functional leukemia-associated antigen-specific memory CD8+ T cells exist in healthy individuals and in patients with chronic myelogenous leukemia before and after stem cell transplantation, Blood 102 [8], pp.2892-900. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12829610

Rich, S.; Seelig, M.; Lee, H. M. and Lin, J. (1995): Transforming growth factor beta 1 costimulated growth and regulatory function of staphylococcal enterotoxin B-responsive CD8+ T cells, J Immunol 155 [2], pp.609-18. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=7608539

Rivoltini, L.; Squarcina, P.; Loftus, D. J.; Castelli, C.; Tarsini, P.; Mazzocchi, A.; Rini, F.; Viggiano, V.; Belli, F. and Parmiani, G. (1999): A superagonist variant of peptide MART1/Melan A27-35 elicits anti-melanoma CD8+ T cells with enhanced functional characteristics: implication for more effective immunotherapy, Cancer Res 59 [2], pp.301-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9927036

Robbins, P. F.; El-Gamil, M.; Li, Y. F.; Fitzgerald, E. B.; Kawakami, Y. and Rosenberg, S. A. (1997): The intronic region of an incompletely spliced gp100 gene transcript encodes an epitope recognized by melanoma-reactive tumor-infiltrating lymphocytes, J Immunol 159 [1], pp.303-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9200467

Roberts, A. B. (2002): The ever-increasing complexity of TGF-beta signaling, Cytokine Growth Factor Rev 13 [1], pp.3-5. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11750874

Rocha, B.; Vassalli, P. and Guy-Grand, D. (1994): Thymic and extrathymic origins of gut intraepithelial lymphocyte populations in mice, J Exp Med 180 [2], pp.681-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=8046341

Roncarolo, M. G. and Levings, M. K. (2000): The role of different subsets of T regulatory cells in controlling autoimmunity, Curr Opin Immunol 12 [6], pp.676-83. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11102772

Ronsin, C.; Chung-Scott, V.; Poullion, I.; Aknouche, N.; Gaudin, C. and Triebel, F. (1999): A non-AUG-defined alternative open reading frame of the intestinal carboxyl esterase mRNA generates an epitope recognized by renal cell carcinoma-reactive tumor-infiltrating lymphocytes in situ, J Immunol 163 [1], pp.483-90. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=10384152

Rouvier, E.; Luciani, M. F. and Golstein, P. (1993): Fas involvement in Ca(2+)-independent T cell-mediated cytotoxicity, J Exp Med 177 [1], pp.195-200. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=7678113

Rubio-Godoy, V.; Ayyoub, M.; Dutoit, V.; Servis, C.; Schink, A.; Rimoldi, D.; Romero, P.; Cerottini, J. C.; Simon, R.; Zhao, Y.; Houghten, R. A.; Pinilla, C. and Valmori, D. (2002): Combinatorial peptide library-based identification of peptide ligands for tumor-reactive cytolytic T lymphocytes of unknown specificity, Eur J Immunol 32 [8], pp.2292-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12209642

Rubio-Godoy, V.; Dutoit, V.; Rimoldi, D.; Lienard, D.; Lejeune, F.; Speiser, D.; Guillaume, P.; Cerottini, J. C.; Romero, P. and Valmori, D. (2001): Discrepancy between ELISPOT IFN-gamma secretion and binding of A2/peptide multimers to TCR reveals interclonal dissociation of CTL effector function from TCR-peptide/MHC complexes half-life, Proc Natl Acad Sci U S A 98 [18], pp.10302-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11517329

Rubio-Godoy, V.; Dutoit, V.; Zhao, Y.; Simon, R.; Guillaume, P.; Houghten, R.; Romero, P.; Cerottini, J. C.; Pinilla, C. and Valmori, D. (2002): Positional scanning-synthetic peptide library-based analysis of self- and pathogen-derived peptide cross-reactivity with tumor-reactive Melan-A-specific CTL, J Immunol 169 [10], pp.5696-707. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12421949

Rudensky, AYu; Preston-Hurlburt, P.; Hong, S. C.; Barlow, A. and Janeway, C. A., Jr. (1991): Sequence analysis of peptides bound to MHC class II molecules, Nature 353 [6345], pp.622-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=1656276

Sahin, U.; Tureci, O.; Schmitt, H.; Cochlovius, B.; Johannes, T.; Schmits, R.; Stenner, F.; Luo, G.; Schobert, I. and Pfreundschuh, M. (1995): Human neoplasms elicit multiple specific immune responses in the autologous host, Proc Natl Acad Sci U S A 92 [25], pp.11810-3. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=8524854

Sakaguchi, S.; Sakaguchi, N.; Shimizu, J.; Yamazaki, S.; Sakihama, T.; Itoh, M.; Kuniyasu, Y.; Nomura, T.; Toda, M. and Takahashi, T. (2001): Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance, Immunol Rev 182, pp.18-32. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11722621

Salazar, E.; Zaremba, S.; Arlen, P. M.; Tsang, K. Y. and Schlom, J. (2000): Agonist peptide from a cytotoxic t-lymphocyte epitope of human carcinoembryonic antigen stimulates production of tc1-type cytokines and increases tyrosine phosphorylation more efficiently than cognate peptide, Int J Cancer 85 [6], pp.829-38. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=10709104

Sallusto, F.; Lenig, D.; Forster, R.; Lipp, M. and Lanzavecchia, A. (1999): Two subsets of memory T lymphocytes with distinct homing potentials and effector functions, Nature 401 [6754], pp.708-12. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=10537110

Sato, N.; Kokame, K.; Shimokado, K.; Kato, H. and Miyata, T. (1998): Changes of gene expression by lysophosphatidylcholine in vascular endothelial cells: 12 up-regulated distinct genes including 5 cell growth-related, 3 thrombosis-related, and 4 others, J Biochem (Tokyo) 123 [6], pp.1119-26. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9604001

Savage, P. A.; Boniface, J. J. and Davis, M. M. (1999): A kinetic basis for T cell receptor repertoire selection during an immune response, Immunity 10 [4], pp.485-92. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=10229191

Schwartz, R. H. (1985): T-lymphocyte recognition of antigen in association with gene products of the major histocompatibility complex, Annu Rev Immunol 3, pp.237-61. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=2415139

Seifert, U.; Maranon, C.; Shmueli, A.; Desoutter, J. F.; Wesoloski, L.; Janek, K.; Henklein, P.; Diescher, S.; Andrieu, M.; de la Salle, H.; Weinschenk, T.; Schild, H.; Laderach, D.; Galy, A.; Haas, G.; Kloetzel, P. M.; Reiss, Y. and Hosmalin, A. (2003): An essential role for tripeptidyl peptidase in the generation of an MHC class I epitope, Nat Immunol 4 [4], pp.375-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12598896

Sell, S.; Becker, F. F.; Leffert, H. L. and Watabe, L. (1976): Expression of an oncodevelopmental gene product (alpha-fetoprotein) during fetal development and adult oncogenesis, Cancer Res 36 [11 Pt. 2], pp.4239-49. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=61804

Seo, N.; Tokura, Y.; Matsumoto, K.; Furukawa, F. and Takigawa, M. (1998): Tumour-specific cytotoxic T lymphocyte activity in Th2-type Sezary syndrome: its enhancement by interferon-gamma (IFN-gamma) and IL-12 and fluctuations in association with disease activity, Clin Exp Immunol 112 [3], pp.403-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9649208

Shevach, E. M.; McHugh, R. S.; Thornton, A. M.; Piccirillo, C.; Natarajan, K. and Margulies, D. H. (2001): Control of autoimmunity by regulatory T cells, Adv Exp Med Biol 490, pp.21-32. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11505971

Shimizu, J.; Yamazaki, S.; Takahashi, T.; Ishida, Y. and Sakaguchi, S. (2002): Stimulation of CD25(+)CD4(+) regulatory T cells through GITR breaks immunological self-tolerance, Nat Immunol 3 [2], pp.135-42. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11812990

Shimono, A.; Okuda, T. and Kondoh, H. (1999): N-myc-dependent repression of ndr1, a gene identified by direct subtraction of whole mouse embryo cDNAs between wild type and N-myc mutant, Mech Dev 83 [1-2], pp.39-52. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=10381566

Slifka, M. K. and Whitton, J. L. (2001): Functional avidity maturation of CD8(+) T cells without selection of higher affinity TCR, Nat Immunol 2 [8], pp.711-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11477407

Sloan, V. S.; Cameron, P.; Porter, G.; Gammon, M.; Amaya, M.; Mellins, E. and Zaller, D. M. (1995): Mediation by HLA-DM of dissociation of peptides from HLA-DR, Nature 375 [6534], pp.802-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=7596415

Speir, J. A.; Garcia, K. C.; Brunmark, A.; Degano, M.; Peterson, P. A.; Teyton, L. and Wilson, I. A. (1998): Structural basis of 2C TCR allorecognition of H-2Ld peptide complexes, Immunity 8 [5], pp.553-62. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9620676

Steiner, M. S.; Zhou, Z. Z.; Tonb, D. C. and Barrack, E. R. (1994): Expression of transforming growth factor-beta 1 in prostate cancer, Endocrinology 135 [5], pp.2240-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=7956947

Stern, L. J.; Brown, J. H.; Jardetzky, T. S.; Gorga, J. C.; Urban, R. G.; Strominger, J. L. and Wiley, D. C. (1994): Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide, Nature 368 [6468], pp.215-21. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=8145819

Sterry, W. and Mielke, V. (1989): CD4+ cutaneous T-cell lymphomas show the phenotype of helper/inducer T cells (CD45RA-, CDw29+), J Invest Dermatol 93 [3], pp.413-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=2527911

Tepper, A. D.; Cock, J. G.; de Vries, E.; Borst, J. and van Blitterswijk, W. J. (1997): CD95/Fas-induced ceramide formation proceeds with slow kinetics and is not blocked by caspase-3/CPP32 inhibition, J Biol Chem 272 [39], pp.24308-12. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9305886

Thangavelu, M.; Finn, W. G.; Yelavarthi, K. K.; Roenigk, H. H., Jr.; Samuelson, E.; Peterson, L.; Kuzel, T. M. and Rosen, S. T. (1997): Recurring structural chromosome abnormalities in peripheral blood lymphocytes of patients with mycosis fungoides/Sezary syndrome, Blood 89 [9], pp.3371-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9129044

Tourdot, S.; Scardino, A.; Saloustrou, E.; Gross, D. A.; Pascolo, S.; Cordopatis, P.; Lemonnier, F. A. and Kosmatopoulos, K. (2000): A general strategy to enhance immunogenicity of low-affinity HLA-A2. 1-associated peptides: implication in the identification of cryptic tumor epitopes, Eur J Immunol 30 [12], pp.3411-21. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11093159

Townsend, A.; Bastin, J.; Gould, K.; Brownlee, G.; Andrew, M.; Coupar, B.; Boyle, D.; Chan, S. and Smith, G. (1988): Defective presentation to class I-restricted cytotoxic T lymphocytes in vaccinia-infected cells is overcome by enhanced degradation of antigen, J Exp Med 168 [4], pp.1211-24. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=2459295

Trefzer, U.; Herberth, G.; Wohlan, K.; Milling, A.; Thiemann, M.; Sherev, T.; Sparbier, K.; Sterry, W. and Walden, P. (2004): Vaccination with hybrids of tumor and dendritic cells induces tumor-specific T-cell and clinical responses in melanoma stage III and IV patients, Int J Cancer 110 [5], pp.730-40. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15146563

Tsamandas, A. C.; Kardamakis, D.; Ravazoula, P.; Zolota, V.; Salakou, S.; Tepetes, K.; Kalogeropoulou, C.; Tsota, I.; Kourelis, T.; Makatsoris, T.; Karavias, D.; Scopa, C. D.; Bonikos, D. S.; Kalofonos, H. P. and Petsas, T. (2004): The potential role of TGFbeta1, TGFbeta2 and TGFbeta3 protein expression in colorectal carcinomas. Correlation with classic histopathologic factors and patient survival, Strahlenther Onkol 180 [4], pp.201-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15057430

Tschopp, J. and Jongeneel, C. V. (1988): Cytotoxic T lymphocyte mediated cytolysis, Biochemistry 27 [8], pp.2641-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=3042021

Tumenjargal, S.; Gellrich, S.; Linnemann, T.; Muche, J. M.; Lukowsky, A.; Audring, H.; Wiesmuller, K. H.; Sterry, W. and Walden, P. (2003): Anti-tumor immune responses and tumor regression induced with mimotopes of a tumor-associated T cell epitope, Eur J Immunol 33 [11], pp.3175-85. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=14579286

Udaka, K.; Wiesmuller, K. H.; Kienle, S.; Jung, G. and Walden, P. (1995): Decrypting the structure of major histocompatibility complex class I-restricted cytotoxic T lymphocyte epitopes with complex peptide libraries, J Exp Med 181 [6], pp.2097-108. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=7539039

Udaka, K.; Wiesmuller, K. H.; Kienle, S.; Jung, G. and Walden, P. (1996): Self-MHC-restricted peptides recognized by an alloreactive T lymphocyte clone, J Immunol 157 [2], pp.670-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=8752916

Valitutti, S. and Lanzavecchia, A. (1997): Serial triggering of TCRs: a basis for the sensitivity and specificity of antigen recognition, Immunol Today 18 [6], pp.299-304. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9190117

Valmori, D.; Dutoit, V.; Schnuriger, V.; Quiquerez, A. L.; Pittet, M. J.; Guillaume, P.; Rubio-Godoy, V.; Walker, P. R.; Rimoldi, D.; Lienard, D.; Cerottini, J. C.; Romero, P. and Dietrich, P. Y. (2002): Vaccination with a Melan-A peptide selects an oligoclonal T cell population with increased functional avidity and tumor reactivity, J Immunol 168 [8], pp.4231-40. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11937585

Valmori, D.; Fonteneau, J. F.; Lizana, C. M.; Gervois, N.; Lienard, D.; Rimoldi, D.; Jongeneel, V.; Jotereau, F.; Cerottini, J. C. and Romero, P. (1998): Enhanced generation of specific tumor-reactive CTL in vitro by selected Melan-A/MART-1 immunodominant peptide analogues, J Immunol 160 [4], pp.1750-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9469433

Valmori, D.; Gervois, N.; Rimoldi, D.; Fonteneau, J. F.; Bonelo, A.; Lienard, D.; Rivoltini, L.; Jotereau, F.; Cerottini, J. C. and Romero, P. (1998): Diversity of the fine specificity displayed by HLA-A*0201-restricted CTL specific for the immunodominant Melan-A/MART-1 antigenic peptide, J Immunol 161 [12], pp.6956-62. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9862730

van Belzen, N.; Dinjens, W. N.; Diesveld, M. P.; Groen, N. A.; van der Made, A. C.; Nozawa, Y.; Vlietstra, R.; Trapman, J. and Bosman, F. T. (1997): A novel gene which is up-regulated during colon epithelial cell differentiation and down-regulated in colorectal neoplasms, Lab Invest 77 [1], pp.85-92. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9251681

van der Bruggen, P.; Traversari, C.; Chomez, P.; Lurquin, C.; De Plaen, E.; Van den Eynde, B.; Knuth, A. and Boon, T. (1991): A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma, Science 254 [5038], pp.1643-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=1840703

Varshavsky, A. (1997): The ubiquitin system, Trends Biochem Sci 22 [10], pp.383-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9357313

Vassilakos, A.; Cohen-Doyle, M. F.; Peterson, P. A.; Jackson, M. R. and Williams, D. B. (1996): The molecular chaperone calnexin facilitates folding and assembly of class I histocompatibility molecules, Embo J 15 [7], pp.1495-506. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=8612572

Verheij, M.; Bose, R.; Lin, X. H.; Yao, B.; Jarvis, W. D.; Grant, S.; Birrer, M. J.; Szabo, E.; Zon, L. I.; Kyriakis, J. M.; Haimovitz-Friedman, A.; Fuks, Z. and Kolesnick, R. N. (1996): Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis, Nature 380 [6569], pp.75-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=8598911

Walunas, T. L.; Lenschow, D. J.; Bakker, C. Y.; Linsley, P. S.; Freeman, G. J.; Green, J. M.; Thompson, C. B. and Bluestone, J. A. (1994): CTLA-4 can function as a negative regulator of T cell activation, Immunity 1 [5], pp.405-13. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=7882171

Wang, H. Y.; Lee, D. A.; Peng, G.; Guo, Z.; Li, Y.; Kiniwa, Y.; Shevach, E. M. and Wang, R. F. (2004): Tumor-specific human CD4+ regulatory T cells and their ligands: implications for immunotherapy, Immunity 20 [1], pp.107-18. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=14738769

Wang-Johanning, F.; Frost, A. R.; Jian, B.; Epp, L.; Lu, D. W. and Johanning, G. L. (2003): Quantitation of HERV-K env gene expression and splicing in human breast cancer, Oncogene 22 [10], pp.1528-35. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12629516

Whiteside, T. L. and Rabinowich, H. (1998): The role of Fas/FasL in immunosuppression induced by human tumors, Cancer Immunol Immunother 46 [4], pp.175-84. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9671140

Willemze, R.; Kerl, H.; Sterry, W.; Berti, E.; Cerroni, L.; Chimenti, S.; Diaz-Perez, J. L.; Geerts, M. L.; Goos, M.; Knobler, R.; Ralfkiaer, E.; Santucci, M.; Smith, N.; Wechsler, J.; van Vloten, W. A. and Meijer, C. J. (1997): EORTC classification for primary cutaneous lymphomas: a proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer, Blood 90 [1], pp.354-71. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9207472

Winter, D.; Fiebiger, E.; Meraner, P.; Auer, H.; Brna, C.; Strohal, R.; Trautinger, F.; Knobler, R.; Fischer, G. F.; Stingl, G. and Maurer, D. (2003): Definition of TCR epitopes for CTL-mediated attack of cutaneous T cell lymphoma, J Immunol 171 [5], pp.2714-24. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12928425

Wolf, P. R. and Ploegh, H. L. (1995): How MHC class II molecules acquire peptide cargo: biosynthesis and trafficking through the endocytic pathway, Annu Rev Cell Dev Biol 11, pp.267-306. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=8689559

Woll, M. M.; Fisher, C. M.; Ryan, G. B.; Gurney, J. M.; Storrer, C. E.; Ioannides, C. G.; Shriver, C. D.; Moul, J. W.; McLeod, D. G.; Ponniah, S. and Peoples, G. E. (2004): Direct Measurement of Peptide-specific Cd8+ T Cells Using Hla-a2:ig Dimer for Monitoring the in Vivo Immune Response to a Her2/neu Vaccine in Breast and Prostate Cancer Patients, J Clin Immunol 24 [4], pp.449-61. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15163902

Woo, E. Y.; Yeh, H.; Chu, C. S.; Schlienger, K.; Carroll, R. G.; Riley, J. L.; Kaiser, L. R. and June, C. H. (2002): Cutting edge: Regulatory T cells from lung cancer patients directly inhibit autologous T cell proliferation, J Immunol 168 [9], pp.4272-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11970966

Yee, C.; Savage, P. A.; Lee, P. P.; Davis, M. M. and Greenberg, P. D. (1999): Isolation of high avidity melanoma-reactive CTL from heterogeneous populations using peptide-MHC tetramers, J Immunol 162 [4], pp.2227-34. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9973498

Yu, J.; Zhang, L.; Hwang, P. M.; Rago, C.; Kinzler, K. W. and Vogelstein, B. (1999): Identification and classification of p53-regulated genes, Proc Natl Acad Sci U S A 96 [25], pp.14517-22. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=10588737

Zheng, S. G.; Wang, J. H.; Koss, M. N.; Quismorio, F., Jr.; Gray, J. D. and Horwitz, D. A. (2004): CD4+ and CD8+ regulatory T cells generated ex vivo with IL-2 and TGF-beta suppress a stimulatory graft-versus-host disease with a lupus-like syndrome, J Immunol 172 [3], pp.1531-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=14734731

Zhou, D.; Salnikow, K. and Costa, M. (1998): Cap43, a novel gene specifically induced by Ni2+ compounds, Cancer Res 58 [10], pp.2182-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9605764

Zoi-Toli, O.; Vermeer, M. H.; De Vries, E.; Van Beek, P.; Meijer, C. J. and Willemze, R. (2000): Expression of Fas and Fas-ligand in primary cutaneous T-cell lymphoma (CTCL): association between lack of Fas expression and aggressive types of CTCL, Br J Dermatol 143 [2], pp.313-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=10951138


© Die inhaltliche Zusammenstellung und Aufmachung dieser Publikation sowie die elektronische Verarbeitung sind urheberrechtlich geschützt. Jede Verwertung, die nicht ausdrücklich vom Urheberrechtsgesetz zugelassen ist, bedarf der vorherigen Zustimmung. Das gilt insbesondere für die Vervielfältigung, die Bearbeitung und Einspeicherung und Verarbeitung in elektronische Systeme.
DiML DTD Version 3.0Zertifizierter Dokumentenserver
der Humboldt-Universität zu Berlin
HTML-Version erstellt am:
17.03.2005